Topping Off the Pill Box Dapagliflozin, Heart Failure, and Polypharmacy

被引：0
|
作者：
Park, Jin Joo [1 ,2 ,3 ]
Greenberg, Barry [1 ]
机构：
[1] Univ Calif San Diego, Cardiol Dept, La Jolla, CA USA
[2] Seoul Natl Univ, Cardiovasc Ctr, Dept Internal Med, Div Cardiol,Bundang Hosp, Seoul, South Korea
[3] Seoul Natl Univ, Dept Internal Med, Cardiovasc Ctr, Div Cardiol,Bundang Hosp, 82,Gumi Ro 173, Seongnam Si 13620, Gyeonggi Do, South Korea
来源：
JACC-HEART FAILURE | 2023年 / 11卷 / 10期
关键词：
dapagliflozin; heart failure with preserved ejection fraction; polypharmacy;
D O I：
10.1016/j.jchf.2023.06.033
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1394 / 1396
页数：3
相关论文
共 50 条
  • [21] Dapagliflozin Safe and Effective for Heart Failure With Frailty
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (20): : 1950 - 1950
  • [22] Dapagliflozin in Heart Failure with Preserved Ejection Fraction
    Zweck, Elric
    Westenfeld, Ralf
    Redfors, Bjorn
    Omerovic, Elmir
    Weir, Robin A. P.
    Gabrielli, Domenico
    Oliva, Fabrizio
    Zuccala, Giuseppe
    Solomon, Scott D.
    Vaduganathan, Muthiah
    McMurray, John J. V.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (03): : 286 - 286
  • [23] Dapagliflozin (Farxiga) - A New Indication for Heart Failure
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1601): : 102 - 103
  • [24] Dapagliflozin Use in Children with Heart Failure Undergoing Heart Transplantation
    Newland, D. M.
    Law, Y. M.
    Albers, E. L.
    Ali, R.
    Friedland-Little, J. M.
    Kemna, M. S.
    Knorr, L. R.
    Nemeth, T. L.
    Spencer, K. L.
    Hong, B. J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S616 - S616
  • [25] Prognostic value of polypharmacy in patients with heart failure
    Fujita, R.
    Takabayashi, K.
    Iwatsu, K.
    Matsumura, K.
    Ikeda, T.
    Kitaguchi, S.
    Nohara, R.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3962 - 3962
  • [26] Polypharmacy in Older Adults Hospitalized for Heart Failure
    Unlu, Ozan
    Levitan, Emily B.
    Reshetnyak, Evgeniya
    Kneifati-Hayek, Jerard
    Diaz, Ivan
    Archambault, Alexi
    Chen, Ligong
    Hanlon, Joseph T.
    Maurer, Mathew S.
    Safford, Monika M.
    Lachs, Mark S.
    Goyal, Parag
    CIRCULATION-HEART FAILURE, 2020, 13 (11) : E006977
  • [27] Medical therapy in heart failure - Is polypharmacy necessary?
    Kwok, BWK
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2004, 33 (04) : 444 - 450
  • [28] Politerapy and polypharmacy in the elderly with chronic heart failure
    Ferrara, Nicola
    Terrosu, Pierfranco
    Zuccala, Giuseppe
    Corsini, Alberto
    GIORNALE ITALIANO DI CARDIOLOGIA, 2013, 14 (03) : 46S - 51S
  • [29] Polypharmacy in Older Adults Hospitalized for Heart Failure
    Goyal, P.
    Unlu, O.
    Kneifati-Hayek, J.
    Levitan, E.
    Chen, L.
    Diaz, I.
    Hanlon, J.
    Lachs, M.
    Maurer, M.
    Safford, M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 68 : S171 - S171
  • [30] Polypharmacy in heart failure - Is reducing medication safe?
    Hopper, Ingrid
    Skiba, Marina
    Windebank, Emma
    Brack, Jane
    Tonkin, Andrew
    Krum, Henry
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 214 : 529 - +
12345